Ardis

Company Overview

Snapshot

Founded in February 2022 by Yehuda Ringel, Ardis operated with 1–10 employees. The company secured $784K in total capital across one funding round from two investors. In May 2022, Ardis received a grant from the Israel Innovation Authority and G.O Innovation to support its development of an all-in-one diagnostic system for pelvic floor disorders.

Business overview

Ardis Medical is a digital health company focused on developing an all-in-one diagnostic system for pelvic floor disorders, including constipation with difficult defecation and fecal incontinence. Their innovative ARDiS system aims to provide a more efficient and cost-effective alternative to existing diagnostic tests, simplifying the assessment process. This technology delivers detailed and precise evaluations of rectal and anorectal functions in a single clinical session, contributing to more accurate diagnoses and personalized treatment options within the health tech and life sciences sectors, specifically digital medical diagnostics and medical devices.

Company Intelligence Q&A

What is the primary focus of Ardis?

Ardis Medical specializes in developing an all-in-one diagnostic system for pelvic floor disorders, such as constipation with difficult defecation and fecal incontinence.

When was Ardis founded?

Ardis was founded in February 2022.

What was a key early funding event for Ardis?

In May 2022, Ardis received a grant from the Israel Innovation Authority and G.O Innovation to support its development of an all-in-one diagnostic system for pelvic floor disorders.

What is the current status of Ardis?

Ardis is currently non-active, having ceased to operate in November 2024.

What technology does Ardis utilize in its diagnostic system?

Ardis leverages artificial intelligence, IoT, and medical data to provide detailed and precise evaluations of rectal and anorectal functions.